These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 13661169

  • 1. Methimazole and carbimazole in hyperthyroidism: a comparison by a double blind technique.
    McGAVACK TH.
    Am J Med Sci; 1959 Jul; 238(1):1-12. PubMed ID: 13661169
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experiences with carbimazole (1-methyl-2-carbethoxy-thio-imidazole) in the treatment of hyperthyroidism.
    MCGAVACK TH, CHEVALLEY J, RECKENDORF HK, HAAR HO.
    J Clin Endocrinol Metab; 1956 Jul; 16(7):887-93. PubMed ID: 13332052
    [No Abstract] [Full Text] [Related]

  • 3. Carbimazole in thyrotoxicosis.
    KIRKEBY K, RØMCKE O.
    Lancet; 1955 Feb 18; 268(6860):374-6. PubMed ID: 13234387
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacology and dosage of thyrostatic drugs].
    Passath A, Leb G, Warnkross H.
    Acta Med Austriaca; 1987 Feb 18; 14(3-4):72-4. PubMed ID: 2447738
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Neomercazole therapy of thyrotoxicosis].
    KIRKEBY K, KAHRS T, ROMCKE O.
    Tidsskr Nor Laegeforen; 1955 Nov 01; 75(21):737-9. PubMed ID: 13291330
    [No Abstract] [Full Text] [Related]

  • 9. Variations in the response of individuals of different ages to an antithyroid compound (methimazole).
    McGAVACK TH, CHEVALLEY J, PEARSON S.
    J Am Geriatr Soc; 1955 Feb 01; 3(2):96-105. PubMed ID: 14353621
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of hyperthyroidism with 1-methyl-2-mercaptoimidazole].
    KLEIN E, WIEDENMANN U.
    Dtsch Med Wochenschr; 1953 Jun 12; 78(24):877-8. PubMed ID: 13068021
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Experience with the thyroid antagonist favistan].
    KLEINDL K.
    Med Klin; 1955 Apr 15; 50(15):672-4. PubMed ID: 14383176
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline; report of 120 cases.
    DONIACH D.
    Lancet; 1953 May 02; 1(6766):873-9. PubMed ID: 13045430
    [No Abstract] [Full Text] [Related]

  • 15. [Experiences with 1-methyl-2-mercaptoimidazole (favistan)].
    REIS H.
    Munch Med Wochenschr; 1955 Jul 15; 97(28):903-4. PubMed ID: 13265622
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of hyperthyroidosis with 1-methyl-2-mercaptiomidazol (mercazole)].
    WURTH K.
    Praxis; 1953 Apr 23; 42(17):331-3. PubMed ID: 13073811
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.